Hexarelin (Examorelin) - Meditech - 2mg × 3 vials
Buy Hexarelin 5mg in India — Meditech Research Grade
Hexarelin - Potent GHRP with Cardioprotection
→ View Hexarelin buying guide for IndiaSynthetic hexapeptide GHRP - one of the most potent GH secretagogues. Unique CD36 cardiac-receptor binding gives it cardioprotective effects independent of GH release.
Order this product
Factory-sealed box: 2mg × 3 vials. Ready for immediate dispatch.
🚚 Pan-India delivery / Cash on Delivery available
Why researchers reach for Hexarelin
Most potent GHRP
Among the strongest GH secretagogues studied - produces sharp, well-characterised GH pulses at modest doses.
Unique CD36 cardioprotection
Binds cardiac CD36 receptors - a property other GHRPs don't share. Supports cardioprotection independent of GH release.
Tissue repair and recovery
GH/IGF-1 axis stimulation supports the same recovery research as other GHRPs, with the cardioprotective bonus.
Neuroprotective signal
Preclinical data shows neuroprotective properties in addition to the GH-release and cardioprotective effects.
Community Insights
Self-reported by pep-pedia.org users and published research summaries. Not clinical evidence.
How Hexarelin Works
GHS-R1a activation
Binds the pituitary ghrelin receptor with greater potency than GHRP-6 (its parent compound), driving stronger GH pulses.
Cardiac CD36 binding
Unique to hexarelin among GHRPs - direct cardiomyocyte CD36 receptor activation provides cardioprotection independent of GH/IGF-1 effects.
GHRH synergy
Like other GHRPs, combines with GHRH-class peptides for supra-additive GH release through dual receptor activation.
Mechanism summary sourced from pep-pedia.org and the published peptide research literature.
Stack It With
Pairs Well
CJC-1295 with DAC
GHRP+GHRH synergy - Hexarelin's strong GHS-R1a activation pairs with sustained GHRH-receptor stimulation for combined GH research.
Pairs Well
MOTS-C
Hexarelin's CD36 cardioprotection plus MOTS-C's mitochondrial AMPK signalling - complementary heart-health and metabolic research targets.
Full Specifications
Frequently Asked Questions
Hexarelin vs GHRP-6?
Hexarelin was developed from GHRP-6 by Mediolanum Farmaceutici with enhanced potency and the unique CD36 cardiac receptor binding. GHRP-6 has stronger appetite-stimulating effects; Hexarelin has cleaner GH release plus cardioprotection.
What is the CD36 effect?
CD36 is a scavenger receptor on cardiomyocytes. Hexarelin binds it directly, providing cardioprotection in ischemia and reperfusion models - entirely independent of the GH-release pathway. This makes it interesting for cardiovascular research beyond GH-axis work.
Why was clinical development discontinued?
Hexarelin reached Phase II trials for GH deficiency and congestive heart failure but was discontinued in 2005 for strategic (not safety) reasons per pep-pedia. The compound itself remains well-characterised in the published literature.
Does it cause cortisol spikes?
Hexarelin produces some cortisol and prolactin elevation - more than the highly-selective Ipamorelin but less than older GHRPs. Research targets where cortisol "noise" matters (sleep, stress models) often favour Ipamorelin instead.
Cycle length?
Pep-pedia documents 8–16 week research cycles. Receptor desensitization can blunt response over longer continuous use; cycling on/off (e.g. 8 weeks on, 4 off) is a common research-protocol approach.
Ready to order
Hexarelin - Meditech
₹6,700 · 2mg × 3 vials · Lyophilized powder + BAC water · Pan-India delivery
Add to CartResearch Use Only
This product is intended solely for laboratory and research purposes. It is not intended for human consumption, therapeutic use, or as a food or drug product. By purchasing, you confirm that this product will be used exclusively for legitimate research applications.